Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
NMI Holdings, Inc. (NMIH - Free Report) : This company that provides private mortgage guaranty insurance services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
America's Car-Mart, Inc. (CRMT - Free Report) : This company that operates as an automotive retailer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.5% over the last 60 days.
comScore, Inc. (SCOR - Free Report) : This company that operates as an information and analytics company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
Emmaus Life Sciences, Inc. (EMMA - Free Report) : This company that engages in the discovery, development, and commercialization of treatments and therapies has witnessed the Zacks Consensus Estimate for its current year earnings increasing 83.3% over the last 60 days.
InterXion Holding N.V. : This company that provides carrier and cloud-neutral colocation data center services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.6% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for today:
NMI Holdings, Inc. (NMIH - Free Report) : This company that provides private mortgage guaranty insurance services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
America's Car-Mart, Inc. (CRMT - Free Report) : This company that operates as an automotive retailer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.5% over the last 60 days.
comScore, Inc. (SCOR - Free Report) : This company that operates as an information and analytics company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
Emmaus Life Sciences, Inc. (EMMA - Free Report) : This company that engages in the discovery, development, and commercialization of treatments and therapies has witnessed the Zacks Consensus Estimate for its current year earnings increasing 83.3% over the last 60 days.
InterXion Holding N.V. : This company that provides carrier and cloud-neutral colocation data center services has witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.6% over the last 60 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on SCOR - FREE
Get the latest research report on CRMT - FREE
Get the latest research report on NMIH - FREE
Get the latest research report on EMMA - FREE